Home care is, by a wide margin, the best-documented Main Street vertical we found while compiling this data. Addus HomeCare, a public company that has built its growth strategy almost entirely around acquiring smaller home care agencies, discloses real purchase prices and revenue figures in its SEC filings — and in at least one case, states its own computed EBITDA multiple outright, which is unusually direct for this size of deal.
Five real transactions
Arcadia Home Care & Staffing (2018): $18.5 million, against $47.4 million in prior-year revenue — roughly 0.39x revenue. Addus stated this represented a trailing EBITDA multiple of 5.5x to 6.5x, giving us both a revenue-basis and an earnings-basis figure for the same deal.
Hospice Partners of America (2019): $130.0 million ($118.4 million net of tax benefits), against approximately $55.0 million in annualized revenue — roughly 2.4x revenue gross, 2.15x net. Notably higher than the personal-care multiple above, which tracks with hospice care's different reimbursement and margin structure.
Gentiva personal care operations (2024): $350 million, adding approximately $280 million in annualized revenue — roughly 1.25x revenue.
HomeCourt Home Care (2026): approximately $12.5 million, against roughly $9.8 million in annual revenue — roughly 1.28x revenue. A far smaller deal than the others, landing at a strikingly similar multiple to Gentiva.
The real finding is the spread, not any single number
Five deals, one acquirer, one general industry — and the computed revenue multiples span from 0.39x to 2.4x. That's not noise. It's the clearest evidence in this whole dataset that "home care" is not one business model with one multiple. Standard personal/companion care, hospice, and staffing-heavy models carry genuinely different margin structures and reimbursement dynamics, and the multiple should — and here, verifiably does — move with that difference, not just with revenue size.
If you're looking at a home care acquisition, the first question isn't "what do home care agencies sell for." It's which of these sub-categories the business actually is, because that answer moves the defensible multiple by several turns, not a fraction of one.
Where the smaller end lands
BizBuySell's aggregate data for "Home Health Care" businesses shows 0.63x revenue and 3.03x SDE at a median sale price of $700,000 — closer to Addus's personal-care-only deals than to its hospice acquisition, which makes sense given size and service mix. The separate "Assisted Living and Nursing Homes" category runs notably higher, at 1.37x revenue and 4.30x SDE, another reminder that the specific service line matters more than the broad label.